CanSORT
TEAM SCIENCE to improve the quality of cancer care for all patients
The Cancer Surveillance & Outcomes Research Team is an interdisciplinary group of investigators dedicated to researching cancer quality of care. We seek to understand and improve how patients and their providers communicate and make decisions about cancer treatments.
Explore CANSort
News
Research News
Steven Katz on How Patients Do and Do Not Share Genetic Test Results
Patient engagement with clinicians and relatives about cascade genetic testing varies by genetic risk in families with hereditary cancer susceptibility, researchers reported in JCO Oncology Practice.
Health Lab
An online intervention can help cancer patients share genetic testing results with family
Katz and colleagues developed a web-based intervention to educate people with cancer about the impact genetic variants can have on their family.
Research News
How Expanding Access to Genetic Testing Can Help Breast Cancer Survivors and Their Families
ACS highlights the groundbreaking work of Dr. Steven Katz, MD, MPH, professor of health management and policy at the University of Michigan. Dr. Katz is an ACS grantee.
Research News
American Cancer Society Research Grantee Improving Breast Cancer Screening & Care Experience
With funding support from the American Cancer Society, Dr. Katz’s team leads the GIFT (Genetic Information and Family Testing) study, an initiative that identifies patients with hereditary cancer predispositions (such as BRCA1 and BRCA2 genes) and engages their families in home-based genetic testing.
Health Lab
Study offers reassurance for patients with some cancer-linked genes
Research by the University of Michigan Health Rogel Cancer Center finds that patients with three of these variants face no extra risk of dying from their cancer.
Research News
Genetic testing for cancer should be the norm now, experts say. Here's when to request it.
Kurian cascade genetic testing Washington Post article
